Patrizia Sini

The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression

K. Smalley, Keiran S M Smalley, Manali S Phadke, 2015, Molecular Cancer Therapeutics.